Biospectrum Singapore: Days after the Drug Controller General of India (DCGI) approved Cadila Healthcare's new chemical entity, Lipaglyn, for launch in India, the company announced its plans for the year 2020.Cadila Healthcare said in ... Bio Spectrum Asia, 1 week ago
Dr Reddy's Laboratories (DRL) and Japan-based Fujifilm Corporation have decided to terminate their memorandum of understanding (MoU) to enter into an exclusive partnership in the generic drugs business for the Japanese market and to establish a ...Pharmacy Choice, 2 weeks ago
With the patent cliff looming large, in the coming few years, biosimilars present a huge opportunity for India which has only come up with its guidelines last year. However, just like Dorothy in the Wizard of Oz, the road ahead is fraught with ...Express Pharma, 2 months ago
on your WebpageAdd Widget >Get your members hooked!